A pricey problem that seems to be growing
Musculoskeletal (MSK) conditions are a pricey and pervasive problem that seems to be growing. Already, more than half of American adults are affected by an MSK condition, and it regularly ranks among the top 2 conditions driving employer healthcare costs.1 But an aging population, remote work (along with its associated poor ergonomics and reduced physical activity) and growing rates of obesity and diabetes are all contributing to a worrisome rise.
Low back pain, for instance, is the leading cause of disability worldwide, and researchers expect its prevalence to increase by 36% by 2050.2 Scientists forecast that the incidence rates of some MSK disorders could more than double by the year 2050.
While prevention can and should be a clear priority, there’s also a need to ensure members experiencing MSK-related concerns seek timely care. Because deferred care doesn’t only impact a member’s current mobility and quality of life, it can also have a dramatic effect on the treatment, healthcare costs and health outcomes they experience later.
With 41% of employers expecting to see higher chronic condition management needs in the future, including for MSK and diabetes, the Business Group on Health noted “the urgency felt by companies to avoid deferred care and the associated late-stage conditions and costs” as a top trend for 2024.3